第一作者单位:[1]Gen Hosp Peoples Liberat Army, Dept Gastrointestinal Oncol, Fifth Med Ctr, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Xu Jianming,Cao Bangwei,Gu Kangsheng,et al.CPGJ602 plus mFOLFOX6 as first-line treatment for patients with KRAS/NRAS/BRAF wild-type metastatic colorectal cancer: A randomized phase II study[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):
APA:
Xu, Jianming,Cao, Bangwei,Gu, Kangsheng,Bai, Yuxian,Li, Wei...&Li, Bihui.(2022).CPGJ602 plus mFOLFOX6 as first-line treatment for patients with KRAS/NRAS/BRAF wild-type metastatic colorectal cancer: A randomized phase II study.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA:
Xu, Jianming,et al."CPGJ602 plus mFOLFOX6 as first-line treatment for patients with KRAS/NRAS/BRAF wild-type metastatic colorectal cancer: A randomized phase II study".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)